THREAD EXPANDS DATAVANT PARTNERSHIP TO LAUNCH FULLY CONFIGURABLE SOLUTION FOR REAL-WORLD DATA LINKAGE
CARY, N.C., Oct. 3, 2023 /PRNewswire/ -- Thread® today announced the launch of a fully configurable tokenization feature on its research platform that connects clinical trial and real-world data. This advancement, which expands Thread's collaboration with Datavant, leverages Datavant's connectivity tools that enable clients to tokenize, match, and link patient records across de-identified datasets while preserving patient privacy in compliance with regulations.
- User-Friendly Trial Tokenization Integration Compliantly and Securely Links Clinical and Real-World Data, Supporting Clients to Generate Enhanced Evidence
CARY, N.C., Oct. 3, 2023 /PRNewswire/ -- Thread® today announced the launch of a fully configurable tokenization feature on its research platform that connects clinical trial and real-world data. - By engaging these tools to connect clinical trial data with real-world data, biopharmaceutical companies can unlock their studies' full potential by generating a longitudinal view of the patient journey.
- This solution supports advancing research data access to provide a deeper understanding of patient outcomes.
- The collaboration between Thread and Datavant underscores their shared vision of an expanded clinical trial landscape.